ArticleCell reports. Medicine2023

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.

Anwaar Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.